Hippocratic AI has formed a partnership with Boston Consulting Group to support the biopharma and medtech industries in implementing generative AI healthcare agents at scale. The collaboration centers on deploying Hippocratic AI’s safety-focused, nondiagnostic agents across administrative and operational healthcare tasks, including medication onboarding, monthly medication reconciliation, responses to hospital and payer policy questions, and EHR assistance. By combining Hippocratic AI’s clinical-grade AI platform with BCG’s strategic and operational expertise, the partnership is intended to help life sciences organizations move beyond pilot programs and translate AI experimentation into enterprise-wide impact.
The partnership positions Hippocratic AI as a key enabler of AI-driven transformation across regulated healthcare and life sciences environments. According to founder and CEO Munjal Shah, the collaboration reflects a shared focus on improving patient outcomes while ensuring AI deployments remain clinically aligned, empathetic, and safe. As biopharma and medtech organizations look to scale AI responsibly, the alliance underscores Hippocratic AI’s growing role in delivering operational support that complements human expertise and accelerates innovation without encroaching on diagnostic or prescribing functions.